Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
| Revenue (TTM) | $25.12B |
| Gross Profit (TTM) | $16.34B |
| EBITDA | $6.95B |
| Operating Margin | 27.20% |
| Return on Equity | 15.10% |
| Return on Assets | 7.92% |
| Revenue/Share (TTM) | $65.71 |
| Book Value | $58.61 |
| Price-to-Book | 5.73 |
| Price-to-Sales (TTM) | 5.01 |
| EV/Revenue | 5.58 |
| EV/EBITDA | 22.21 |
| Quarterly Earnings Growth (YoY) | 55.90% |
| Quarterly Revenue Growth (YoY) | 11.40% |
| Shares Outstanding | $382.69M |
| Float | $346.57M |
| % Insiders | 5.40% |
| % Institutions | 82.23% |
Volatility is currently expanding